Trade Names: | |
Synonyms: | |
Status: | Approved (1995) |
Entry Type: | Small molecule |
Molecule Category: | Salt Prodrug |
UNII: | G447S0T1VC |
Parent Compound: | VALACYCLOVIR |
InChI Key | ZCDDBUOENGJMLV-QRPNPIFTSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C13H21ClN6O4 |
Molecular Weight | 360.8 |
AlogP | -0.8 |
Hydrogen Bond Acceptor | 9.0 |
Hydrogen Bond Donor | 3.0 |
Number of Rotational Bond | 7.0 |
Polar Surface Area | 151.14 |
Molecular species | NEUTRAL |
Aromatic Rings | 2.0 |
Heavy Atoms | 23.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Human herpesvirus 1 DNA polymerase inhibitor | FDA |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 69 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Cytomegalovirus Infections | 3 | D003586 | ClinicalTrials |
Psychotic Disorders | 2 | D011618 | ClinicalTrials |
Schizophrenia | 2 | D012559 | ClinicalTrials |
Uveitis, Anterior | 2 | D014606 | ClinicalTrials |
HIV Infections | 1 | D015658 | ClinicalTrials |
Herpes Simplex | 1 | D006561 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 9919 |
ChEMBL | CHEMBL1201110 |
EPA CompTox | DTXSID2044210 |
FDA SRS | G447S0T1VC |
Guide to Pharmacology | 4824 |
KEGG | C07184 |
PubChem | 135398741 |
SureChEMBL | SCHEMBL40830 |
ZINC | ZINC01530713 |